相似文献
1
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
Antimicrob Agents Chemother. 2007 Apr;51(4):1553-5. doi: 10.1128/AAC.01405-06. Epub 2007 Jan 29.
2
Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.
Antimicrob Agents Chemother. 2004 Nov;48(11):4438-40. doi: 10.1128/AAC.48.11.4438-4440.2004.
3
[Metallo-beta-lactamase-mediated resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates].
Rev Med Chir Soc Med Nat Iasi. 2011 Oct-Dec;115(4):1208-13.
4
Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Pathol Biol (Paris). 2009 Nov-Dec;57(7-8):530-5. doi: 10.1016/j.patbio.2008.09.001. Epub 2008 Oct 31.
5
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
J Antimicrob Chemother. 2011 Sep;66(9):2022-7. doi: 10.1093/jac/dkr232. Epub 2011 Jun 8.
6
Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina.
Antimicrob Agents Chemother. 2005 Jan;49(1):474-5. doi: 10.1128/AAC.49.1.474-475.2005.
7
Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France.
Clin Microbiol Infect. 2006 Sep;12(9):941-2. doi: 10.1111/j.1469-0691.2006.1532_1.x.
8
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.
Clin Infect Dis. 2004 Jul 1;39(1):55-60. doi: 10.1086/421495. Epub 2004 Jun 14.
9
A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
J Antimicrob Chemother. 2007 Jul;60(1):132-5. doi: 10.1093/jac/dkm126. Epub 2007 May 4.
10
Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
J Antimicrob Chemother. 2011 Oct;66(10):2298-307. doi: 10.1093/jac/dkr290. Epub 2011 Jul 20.
引用本文的文献
1
Carbapenemases producing gram-negative bacteria surveillance in Latin America and the caribbean: a retrospective observational study from 2015 to 2020.
Lancet Reg Health Am. 2025 Jul 15;49:101185. doi: 10.1016/j.lana.2025.101185. eCollection 2025 Sep.
2
Systematic review and meta-analysis on the carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates.
BMC Pharmacol Toxicol. 2025 Jan 30;26(1):25. doi: 10.1186/s40360-025-00857-8.
3
Insights into Kinases of ESKAPE Pathogens for Therapeutic Interventions.
Cardiovasc Hematol Agents Med Chem. 2024;22(3):276-297. doi: 10.2174/0118715257267497231128093529.
4
Rapid Reversal of Carbapenemase-Producing Epidemiology from - to -harbouring Isolates in a Greek Tertiary Care Hospital.
Antibiotics (Basel). 2024 Aug 12;13(8):762. doi: 10.3390/antibiotics13080762.
5
16S rRNA amplicon sequencing and antimicrobial resistance profile of intensive care units environment in 41 Brazilian hospitals.
Front Public Health. 2024 Jul 15;12:1378413. doi: 10.3389/fpubh.2024.1378413. eCollection 2024.
6
Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia.
Microbiol Spectr. 2024 Jun 4;12(6):e0171423. doi: 10.1128/spectrum.01714-23. Epub 2024 Apr 17.
7
Draft genome of the 24Kpn33 and complete sequence of its pCOL-1, a plasmid related to the acquisition in .
Microbiol Resour Announc. 2024 Apr 11;13(4):e0007124. doi: 10.1128/mra.00071-24. Epub 2024 Mar 18.
8
Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Clinical Strains: A Challenge for Tertiary Care Hospitals.
Antibiotics (Basel). 2024 Feb 16;13(2):191. doi: 10.3390/antibiotics13020191.
9
The carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam.
Antibiotics (Basel). 2023 Dec 31;13(1):40. doi: 10.3390/antibiotics13010040.
10
Resistance in : A Narrative Review of Antibiogram Interpretation and Emerging Treatments.
Antibiotics (Basel). 2023 Nov 12;12(11):1621. doi: 10.3390/antibiotics12111621.
本文引用的文献
1
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.
Antimicrob Agents Chemother. 2007 Feb;51(2):763-5. doi: 10.1128/AAC.01053-06. Epub 2006 Dec 4.
2
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).
Diagn Microbiol Infect Dis. 2006 Dec;56(4):367-72. doi: 10.1016/j.diagmicrobio.2006.07.004. Epub 2006 Oct 3.
3
Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.
Antimicrob Agents Chemother. 2006 Sep;50(9):3098-101. doi: 10.1128/AAC.00438-06.
4
Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.
Antimicrob Agents Chemother. 2006 Sep;50(9):2941-5. doi: 10.1128/AAC.00116-06.
5
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S49-56. doi: 10.1086/504477.
6
First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.
Antimicrob Agents Chemother. 2006 Aug;50(8):2880-2. doi: 10.1128/AAC.00186-06.
7
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
Int J Antimicrob Agents. 2006 Apr;27(4):351-3. doi: 10.1016/j.ijantimicag.2006.01.004. Epub 2006 Mar 24.
8
First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia.
Antimicrob Agents Chemother. 2006 Jan;50(1):226-9. doi: 10.1128/AAC.50.1.226-229.2006.
9
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France.
Antimicrob Agents Chemother. 2005 Oct;49(10):4423-4. doi: 10.1128/AAC.49.10.4423-4424.2005.
10
Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York.
Antimicrob Agents Chemother. 2005 Feb;49(2):776-8. doi: 10.1128/AAC.49.2.776-778.2005.
Zotero 插件